Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LURASIDONE vs LUSPATERCEPT-AAMT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LURASIDONE vs LUSPATERCEPT-AAMT: Safety Overview

Metric LURASIDONE LUSPATERCEPT-AAMT
Total FAERS Reports 17,232 1,683
Deaths Reported 709 246
Death Rate 4.1% 14.6%
Hospitalizations 2,381 308
Average Patient Age 40.7 yrs 73.1 yrs
% Female Patients 68.2% 43.2%
FDA Approval Date Apr 26, 2012 N/A
Manufacturer Ascend Laboratories, LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription